Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Clinical trial NCT01591161 · COMPLETED

Trial details

NCT number: NCT01591161
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cataract Inflammation Surgery

Start date: 2012-07-01
Primary completion: 2013-06-01
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.